{"id":"NCT03834766","sponsor":"Tris Pharma, Inc.","briefTitle":"Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD","officialTitle":"Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-02-06","primaryCompletion":"2019-10-19","completion":"2019-10-19","firstPosted":"2019-02-08","resultsPosted":"2023-11-02","lastUpdate":"2023-11-02"},"enrollment":130,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["ADHD"],"interventions":[{"type":"DRUG","name":"AMPH ER Tab 5, 10, 15 and 20 mg","otherNames":["Amphetamine Extended Release Tablets"]},{"type":"DRUG","name":"AMPH ER Tab Matching Placebo 5, 10, 15 and 20 mg","otherNames":["Amphetamine Extended Release Tablets Matching Placebo"]}],"arms":[{"label":"AMPH ER Tab","type":"ACTIVE_COMPARATOR"},{"label":"Matching Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the efficacy of AMPH ER TAB compared to placebo in adult patients with ADHD aged 18 to 60 years.","primaryOutcome":{"measure":"Lean Squares Mean (Â± Standard Error) of Math Test Score Over All Post-dose Time Points (0.5, 1, 2, 4, 8, 10, 12, 13, and 14 Hours Post-dose) Assessed During the Administration of Serial Math Tests at Visit 5 (Week 5)","timeFrame":"Pre-dose to 14 hour post-dose","effectByArm":[{"arm":"AMPH ER Tab","deltaMin":259.5,"sd":69.4},{"arm":"Matching Placebo","deltaMin":260.6,"sd":77.75}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":3,"countries":["United States"]},"refs":{"pmids":["35857716"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":62},"commonTop":["Decreased Appetite","Insomnia","Irritability","Dry Moutn","Headache"]}}